Clinical Trial Update: Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients. [NA]

View source ↗

Summary

A completed clinical trial assessed how short-chain fatty acid supplementation alters metabolic profiles in serum and urine among kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Short-chain fatty acids (SCFA) supplementation (short-chain fatty acids)

Snippet

Sponsor: University Hospital, Martin | Conditions: Metabolic Effects, Immunosuppressive Agents | NA | Status: COMPLETED